University · founded 1911
Anderson University - South Carolina
Anderson, United States · andersonuniversity.edu
- Citations, last 5 years
- 1 240
- Works, last 5 years
- 169
- h-index
- 34
- Scientists listed
- 11
- Grants since 2016
- 1 743
Grants received
2021–2026 · research · R01
Alzheimer's Disease Pathology in a Primate Model
William D Hopkins · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
David R Grosshans · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis
Michael Richard Green · Anderson University - South Carolina · funded by National Institutes of Health
2021–2024 · fellowship · F32
Elucidating the role of gut, blood, and tumor microbiota in brain metastasis
Golnaz Morad · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis
Michael Richard Green · Anderson University - South Carolina · funded by National Institutes of Health
2021–2023 · research · R21
GS-441524 is Pharmacodynamically Equivalent to Remdesivir and Pharmacokinetically Superior Drug for the Treatment of COVID-19
Chun Li · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
Giannicola Genovese · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
Min Sup Song · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Pro-Drug Enolase Inhibitors in Precision Oncology
Steven W Millward · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Promoting HPV Vaccination among Young Adults in Texas
Qian Lu · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
Min Sup Song · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
Hesham M Amin · Anderson University - South Carolina · funded by National Institutes of Health
2021–2025 · research · R01
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology
Ruitao Lin · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer
Andrea Viale · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2
Jonathan M Kurie · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2
Jonathan M Kurie · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer
Humam Kadara · Anderson University - South Carolina · funded by National Institutes of Health
2021–2025 · research · R01
Novel combination therapy for AML expressing mutant RUNX1
Kapil Bhalla · Anderson University - South Carolina · funded by National Institutes of Health
2021–2024 · research · R21
A Squirrel Monkey Model of Alzheimer’s Disease: Developing Behavioral, Blood, and CSF Biomarkers
William D Hopkins · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Alzheimer's Disease Pathology in a Primate Model
William D Hopkins · Anderson University - South Carolina · funded by National Institutes of Health
2021–2023 · research · R21
Role of β-lactamase encoding gene amplification in the development of non-carbapenemase producing, carbapenem-resistant Enterobacteriaceae
Samuel A Shelburne · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
Juan Fueyo · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer
Andrea Viale · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
Shiaw-Yih Lin · Anderson University - South Carolina · funded by National Institutes of Health
2021–2025 · research · R01
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology
Ruitao Lin · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Cancer Immune-Interception for Lynch Syndrome
Steven M Lipkin · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors
Qian Lu · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Developing novel bispecific antibodies for cancer treatment
Zhen Fan · Anderson University - South Carolina · funded by National Institutes of Health
2021–2024 · research · R01
Integrative Brain Network-Based Analysis for Heterogeneous and Multimodal
Suprateek Kundu · Anderson University - South Carolina · funded by National Institutes of Health
2021–2023 · career development · K99
A pro-metastatic secretory program activated by epithelial-to-mesenchymal transition
Guan-Yu Xiao · Anderson University - South Carolina · funded by National Institutes of Health
2021–2025 · research · R01
Bayesian Methods for Complex Precision Biotherapy Trials in Oncology
Ruitao Lin · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · career development · K08
Elucidating Human Leukemia and T Cell Interactions within the Tumor Microenvironment
Pavan Bachireddy · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
Tina Cascone · Anderson University - South Carolina · funded by National Institutes of Health
2021–2025 · research · R01
Novel combination therapy for AML expressing mutant RUNX1
Kapil Bhalla · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R50
Targeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC)
Monique B Nilsson · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Peer-Based Approaches to Enhance Physical Activity in Dyads of Inactive Women
Larkin Strong · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R01
Analyzing the Endothelial Cell-Expressed Prion Gene Prnd in Vascular Development
Joseph H Mccarty · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · career development · K01
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy
Noha Abdelwahab Hassan Ali Hassan · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R35
ERK-mediated regulation of non-coding RNAs during development and disease
Swathi Arur · Anderson University - South Carolina · funded by National Institutes of Health
2021–2026 · research · R35
ERK-mediated regulation of non-coding RNAs during development and disease
Swathi Arur · Anderson University - South Carolina · funded by National Institutes of Health